W. Wallace

Interpreting human follicular recruitment and antimüllerian hormone concentrations throughout life.

Richard A. Anderson, Richard Fleming, W. Wallace, 2012, Fertility and sterility.

Data-driven assessment of the human ovarian reserve.

R. Anderson, W. Wallace, S. Nelson, 2012, Molecular human reproduction.

Measuring anti-Müllerian hormone for the assessment of ovarian reserve: when and for whom is it indicated?

S. Nelsonb, R. Andersona, W.H.B. Wallacec, 2012, Maturitas.

Diethylstilboestrol Exposure Does Not Reduce Testosterone Production in Human Fetal Testis Xenografts

Lee B. Smith, R. Sharpe, W. Wallace, 2013, PloS one.

Xenografting of human fetal testis tissue: a new approach to study fetal testis development and germ cell differentiation

R. Sharpe, P. Saunders, W. Wallace, 2010, Human reproduction.

The physiology and clinical utility of anti-Mullerian hormone in 1 women 2

R. Fanchin, A. Marca, Jenny A. Visser, 2015 .

Anti-Müllerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study.

Richard A. Anderson, W. Wallace, M. Brougham, 2012, The Journal of clinical endocrinology and metabolism.

Optimizing reproductive outcome in children and young people with cancer.

Richard A. Anderson, W. Wallace, Hilary O. D. Critchley, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ovarian cryopreservation for fertility preservation: indications and outcomes.

D. Baird, R. Anderson, W. Wallace, 2008, Reproduction.

Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation

W. Wallace, T. Kelsey, R. Anderson, 2014, The Lancet. Oncology.

Ovarian tissue cryopreservation for fertility preservation: clinical and research perspectives

W. Wallace, E. Telfer, R. Anderson, 2017, Human reproduction open.